Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, writes Ken Squire of 13D Monitor…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

two × two =